Robert J Zamboni

This inventor holds 39 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Frosst Canada, Inc., Aeromics, Inc., Merck Frosst Canada & Co.. Active years: 1987-2026.

USPTO Granted Patents = 39 (Patent Applications = 8)

% Patents Active = 94.9

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 207(Granted Patents)

Location History:

Point-Clair, CA (1992)
Longueuil, CA (1987 - 1995)
Point-Claire, CA (1993 - 1996)
Quebec, CA (2003)
Pointe-Claire, CA (1992 - 2006)
Toronto, CA (2018)
Beaconsfield, CA (2012 - 2024)

Company Filing History:

17 out of 212

Merck Frosst Canada, Inc.

Merck Frosst Canada & Co.

patents

4. 3 out of 281

St. Jude Children's Research Hospital

patents

5. 2 out of 2

Coa Therapeutics, Inc.

patents

6. 2 out of 22

Debiopharm International, S.a.

Cantero Therapeutics, Inc.

Zamboni Chem Solutions Inc.

patent

where one patent can have more than one assignee

Years Active: 1987-2026

Loading Chart...

Areas of Expertise:

Prodrug Salts

Leukotriene Antagonists

Pantothenate Kinase Modulators

Crystals

Gamma-Ketoacid Tetrapeptides

Pyridopyridazine Compounds

Stereoselective Synthesis

Pyrazinones

Substituted Tetrahydrocarbazole

Benzothiazoles

2-Substituted Quinoline

Triphenyl Methanethiol

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545663 - Small molecule modulators of pantothenate kinases (2026-02-10),

2. 12213987 - Prodrug salts (2025-02-04),

3. 12091431 - Crystals (2024-09-17),

4. 11891378 - Small molecule modulators of pantothenate kinases (2024-02-06),

5. 11725018 - Crystals (2023-08-15),

6. 11547709 - Methods of treating disorders associated with castor (2023-01-10),

7. 11401246 - Triazole glycolate oxidase inhibitors (2022-08-02),

8. 11117909 - Crystals (2021-09-14),

9. 11071744 - Prodrug salts (2021-07-27),

10. 10787443 - RAF-degrading conjugate compounds (2020-09-29),

11. 10258636 - Prodrug salts (2019-04-16),

12. 10035813 - Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide (2018-07-31),

13. 9827253 - Prodrug salts (2017-11-28),

14. 8901105 - Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide (2014-12-02),

15. 8222251 - Pyridopyridazine compounds, compositions and methods of use (2012-07-17),

Title: The Innovative Journey of Robert J. Zamboni

Introduction: Robert J. Zamboni is a pioneering inventor based in Longueuil, Canada, known for his groundbreaking contributions to the field of technology and engineering.

Latest Patents: Robert J. Zamboni holds several patents in the areas of renewable energy systems, advanced robotics, and sustainable transportation solutions, showcasing his commitment to creating a more efficient and eco-friendly world.

Career Highlights: With a career spanning over two decades, Robert J. Zamboni has established himself as a visionary inventor with a keen focus on developing cutting-edge technologies that have the potential to revolutionize various industries.

Collaborations: Throughout his career, Robert J. Zamboni has collaborated with leading research institutions, innovative companies, and talented individuals to bring his inventions to life and make a lasting impact on the world.

Conclusion: Robert J. Zamboni's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a trailblazing inventor in the realm of technology and engineering.